Daiichi Sankyo Inc.

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 16,000+ employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We believe that by proactively embracing individual diversity among all employees in the Daiichi Sankyo Group, we will be able to maximize our abilities, leading to global business development and creating innovation. We are working to create a culture of mutual respect among employees from both global and domestic perspectives based on this belief.

Our Strength in Oncology

In alignment with our 2025 Vision “Global Pharma Innovator with Competitive Advantage in Oncology”, our mission in the oncology area is to leverage our world-class, innovative science and push beyond traditional thinking in order to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do.